Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 1.82 lakh shares by 10:46 IST on BSE, a 17.18 times surge over two-week average daily volume of 10602 shares
Bajaj Auto, Bank Of India, Glaxo, ICICI Lombard, Torrent Pharma, Uno Minda: Dividend Record Date: Last Day To Buy Shares To Qualify
Dividend Record Date: Last Day To Buy Shares To Qualify
GSK's Calpol a well-known trademark: High Court
The Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals' pain and fever medicine, Calpol, as a well-known trademark. This designation acknowledges Calpol's extensive recognition in India since 1991. The court found that consumers associate the brand exclusively with GSK due to its long and continuous use.
GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr
Glaxosmithkline Pharmaceuticals rose 1.65% to Rs 2,446.60 after its standalone net profit jumped 5.68% to Rs 274.94 crore on 2.38% increase in revenue from operations to Rs 989.15 crore in Q4 FY26 over Q4 FY25.
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
Sales rise 2.15% to Rs 995.30 crore
GSK Pharma Q4 PAT rises 6% YoY to Rs 275 cr
Glaxosmithkline Pharmaceuticals' standalone net profit jumped 5.68% to Rs 274.94 crore on 2.38% increase in revenue from operations to Rs 989.15 crore in Q4 FY26 over Q4 FY25.
Alembic Pharma gets USFDA nod for generic drug
Alembic Pharmaceuticals has secured approval from the US health regulator for a generic seizure medication. The company received final clearance from the USFDA for Lamotrigine orally disintegrating tablets. This drug is therapeutically equivalent to GlaxoSmithKline's Lamictal. It is used for various seizure types in patients aged two and older. The market for this medication is estimated at USD 27 million.